Book contents
- Genome Editing and Engineering
- Genome Editing and Engineering
- Copyright page
- Dedication
- Contents
- Contributors
- Foreword
- Preface
- Part I Biology of Endonucleases (Zinc-Finger Nuclease, TALENs and CRISPRs) and Regulatory Networks
- Part II Genome Editing in Model Organisms
- Part III Technology Development and Screening
- Part IV Genome Editing in Stem Cells and Regenerative Biology
- Part V Genome Editing in Disease Biology
- 21 CRISPR/Cas9-based In Vivo Models of Cancer
- 22 Inducible CRISPR-based Genome Editing for the Characterization of Cancer Genes
- 23 Genome Editing for Retinal Diseases
- 24 Manipulation of Long Non-coding RNAs in Cardiovascular Disease Using Genome Editing Technology
- 25 Gene Silencing, Disruption and Latency Reactivation with RNA-based and Gene Editing CRISPR/Cas, ZFN and TALEN Technologies for HIV-1/AIDS Therapies
- 26 Use of the CRISPR/Cas9 System for Genome Editing of Immune System Cells, Defense Against HIV-1 and Cancer Therapies
- 27 Harnessing the Therapeutic Potential of Long Non-coding RNAs in Immunity
- Part VI Legal (Intellectual Property) and Bioethical Issues of Genome Editing
- Index
- Plate Section (PDF Only)
- References
27 - Harnessing the Therapeutic Potential of Long Non-coding RNAs in Immunity
from Part V - Genome Editing in Disease Biology
Published online by Cambridge University Press: 30 July 2018
Book contents
- Genome Editing and Engineering
- Genome Editing and Engineering
- Copyright page
- Dedication
- Contents
- Contributors
- Foreword
- Preface
- Part I Biology of Endonucleases (Zinc-Finger Nuclease, TALENs and CRISPRs) and Regulatory Networks
- Part II Genome Editing in Model Organisms
- Part III Technology Development and Screening
- Part IV Genome Editing in Stem Cells and Regenerative Biology
- Part V Genome Editing in Disease Biology
- 21 CRISPR/Cas9-based In Vivo Models of Cancer
- 22 Inducible CRISPR-based Genome Editing for the Characterization of Cancer Genes
- 23 Genome Editing for Retinal Diseases
- 24 Manipulation of Long Non-coding RNAs in Cardiovascular Disease Using Genome Editing Technology
- 25 Gene Silencing, Disruption and Latency Reactivation with RNA-based and Gene Editing CRISPR/Cas, ZFN and TALEN Technologies for HIV-1/AIDS Therapies
- 26 Use of the CRISPR/Cas9 System for Genome Editing of Immune System Cells, Defense Against HIV-1 and Cancer Therapies
- 27 Harnessing the Therapeutic Potential of Long Non-coding RNAs in Immunity
- Part VI Legal (Intellectual Property) and Bioethical Issues of Genome Editing
- Index
- Plate Section (PDF Only)
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Genome Editing and EngineeringFrom TALENs, ZFNs and CRISPRs to Molecular Surgery, pp. 414 - 420Publisher: Cambridge University PressPrint publication year: 2018
References
Atianand, MK, Fitzgerald, KA. 2014. Long non-coding RNAs and control of gene expression in the immune system. Trends Mol Med 20: 623–631.CrossRefGoogle ScholarPubMed
Atianand, MK, Hu, W, Satpathy, AT, et al. 2016. A long noncoding RNA lincRNA-EPS acts as a transcriptional brake to restrain inflammation. Cell 165: 1672–1685.CrossRefGoogle ScholarPubMed
Carpenter, S, Aiello, D, Atianand, MK, et al. 2013. A long noncoding RNA mediates both activation and repression of immune response genes. Science 341: 789–792.CrossRefGoogle ScholarPubMed
Cech, TR, Steitz, JA. 2014. The noncoding RNA revolution – trashing old rules to forge new ones. Cell 157: 77–94.CrossRefGoogle ScholarPubMed
Chan, J, Atianand, M, Jiang, Z, et al. 2015. Cutting edge: a natural antisense transcript, AS-IL1alpha, controls inducible transcription of the proinflammatory cytokine IL-1alpha. J Immunol 195: 1359–1363.CrossRefGoogle Scholar
Gomez, JA, Wapinski, OL, Yang, YW, et al. 2013. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-gamma locus. Cell 152: 743–754.CrossRefGoogle ScholarPubMed
Hu, G, Gong, AY, Wang, Y, et al. 2016. LncRNA-Cox2 promotes late inflammatory gene transcription in macrophages through modulating SWI/SNF-mediated chromatin remodeling. J Immunol 196: 2799–2808.CrossRefGoogle Scholar
Hu, G, Tang, Q, Sharma, S, et al. 2013. Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation. Nat Immunol 14: 1190–1198.CrossRefGoogle Scholar
Huang, W, Thomas, B, Flynn, RA, et al. 2015. DDX5 and its associated lncRNA Rmrp modulate TH17 cell effector functions. Nature 528: 517–522.CrossRefGoogle ScholarPubMed
Imamura, K, Imamachi, N, Akizuki, G, et al. 2014. Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. Mol Cell 53: 393–406.CrossRefGoogle ScholarPubMed
Kotzin, JJ, Spencer, SP, McCright, SJ, et al. 2016. The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan. Nature 537: 239–243.CrossRefGoogle Scholar
Krawczyk, M, Emerson, BM. 2014. p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-kappaB complexes. eLife 3: e01776.CrossRefGoogle ScholarPubMed
Maass, PG, Luft, FC, Bahring, S. 2014. Long non-coding RNA in health and disease. J Mol Med 92: 337–346.CrossRefGoogle ScholarPubMed
Mayama, T, Marr, AK, Kino, T. 2016. Differential expression of glucocorticoid receptor noncoding RNA repressor Gas5 in autoimmune and inflammatory diseases. Horm Metab Res 48: 550–557.Google ScholarPubMed
Messemaker, TC, Frank-Bertoncelj, M, Marques, RB, et al. 2016. A novel long non-coding RNA in the rheumatoid arthritis risk locus TRAF1-C5 influences C5 mRNA levels. Genes Immun 17: 85–92.CrossRefGoogle ScholarPubMed
Muller, N, Doring, F, Klapper, M, et al. 2014. Interleukin-6 and tumour necrosis factor-alpha differentially regulate lincRNA transcripts in cells of the innate immune system in vivo in human subjects with rheumatoid arthritis. Cytokine 68: 65–68.CrossRefGoogle ScholarPubMed
Pang, KC, Dinger, ME, Mercer, TR, et al. 2009. Genome-wide identification of long noncoding RNAs in CD8+ T cells. J Immunol 182: 7738–7748.CrossRefGoogle ScholarPubMed
Peng, X, Gralinski, L, Armour, CD, et al. 2010. Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling. MBio 1(5): e00206-10.CrossRefGoogle ScholarPubMed
Qiao, YQ, Huang, ML, Xu, AT, et al. 2013. LncRNA DQ786243 affects Treg related CREB and Foxp3 expression in Crohn’s disease. J Biomed Sci 20: 87.CrossRefGoogle ScholarPubMed
Ranzani, V, Rossetti, G, Panzeri, I, et al. 2015. The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4. Nat Immunol 16: 318–325.CrossRefGoogle Scholar
Rapicavoli, NA, Qu, K, Zhang, J, et al. 2013. A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. eLife 2: e00762.CrossRefGoogle Scholar
Sharma, S, Findlay, GM, Bandukwala, HS, et al. 2011. Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex. Proc Natl Acad Sci USA 108: 11381–11386.CrossRefGoogle ScholarPubMed
Sun, L, Xue, H, Jiang, C, et al. 2016. LncRNA DQ786243 contributes to proliferation and metastasis of colorectal cancer both in vitro and in vivo. Biosci Rep 36(3): e00328.CrossRefGoogle ScholarPubMed
Wang, P, Xue, Y, Han, Y, et al. 2014. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science 344: 310–313.CrossRefGoogle ScholarPubMed
Wang, Y, Zhong, H, Xie, X, et al. 2015. Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci USA 112: E3883–E3892.Google ScholarPubMed
Xia, F, Dong, F, Yang, Y, et al. 2014. Dynamic transcription of long non-coding RNA genes during CD4+ T cell development and activation. PLoS One 9: e101588.CrossRefGoogle ScholarPubMed
Zhao, G, Su, Z, Song, D, Mao, Y, Mao, X. 2016. The long noncoding RNA MALAT1 regulates the lipopolysaccharide-induced inflammatory response through its interaction with NF-kappaB. FEBS Lett 590: 2884–2895.CrossRefGoogle Scholar